PrEP Implementation Science with Hard to Reach Populations in India
印度难以接触人群的 PrEP 实施科学
基本信息
- 批准号:10369556
- 负责人:
- 金额:$ 18.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAddressAdherenceAdoptedAdoptionApplications GrantsAustraliaCOVID-19CaliforniaCaringContinuity of Patient CareCountryDataDiscriminationDoctor of PhilosophyEastern AfricaEffectivenessEpidemicEpidemiologistEvaluationEvidence based practiceFacultyFamilyFemaleFundingGoalsHIVHealthHealthcareIncidenceIndiaInterventionInterviewLeftLos AngelesMentorsMethodologyMethodsModelingMonitorNIH Office of AIDS ResearchNigeriaOccupationsOralPatientsPersonsPilot ProjectsPoliciesPopulationPrevalenceProviderPsychiatryRandomized Controlled TrialsRecordsReportingResearchResearch InstituteResearch PersonnelResearch PriorityResearch TrainingRiskRuralSafetyScienceSelf ManagementSexual and Gender MinoritiesSiteSouth AfricaSouthern AfricaStigmatizationStrategic PlanningTestingTrainingUnited StatesUnited States National Institutes of HealthUniversitiesVertebral columnViolenceWorkbarrier to carebasebiobehaviorcare systemscareerchronic care modelconcept mappingdesigndigitaleHealthefficacy evaluationevidence baseexperienceexperimental studyfemale sex workerfollow-upgender minority groupgender minority healthglobal healthhealth disparityimplementation evaluationimplementation frameworkimplementation outcomesimplementation processimplementation scienceimplementation toolinnovationmalemobile computingnovelorganizational readinessoutreach clinicspilot testpre-exposure prophylaxispreferenceprevention serviceprototypepublic health researchresearch and developmentscale upself testingsexskillssocialsocial exclusionstaff interventionstressorsuccesstooltransgenderuptake
项目摘要
PROJECT SUMMARY/ABSTRACT
Anne E. Fehrenbacher, PhD, MPH is a social epidemiologist in the Department of Psychiatry and
Biobehavioral Sciences at the University of California, Los Angeles and a Fogary GloCal Fellow at the Public
Health Research Institute of India. Dr. Fehrenbacher’s long-term career goal is to become an independent
investigator with expertise in implementation science for HIV interventions with stigmatized populations. The
proposed K01 research and training plan will provide Dr. Fehrenbacher with the methodological and practical
skills to meet this goal. The present study will evaluate the acceptability, feasibility, and sustainability of an
adapted WHO E-PrEP Implementation Tool to increase PrEP uptake, retention, and adherence.
Dr. Fehrenbacher’s research plan will address three specific aims guided by the EPIS Framework of
Implementation Science: 1) to model barriers and facilitators at the policy, structural, and organizational levels
for adopting the WHO E-PrEP Implementation Tool to support PrEP rollout in targeted interventions in India; 2)
to assess patient and provider preferences for bundled intervention components to inform the adaptation,
localization, and tailoring of the WHO E-PrEP Implementation Tool; and 3) to evaluate the acceptability,
feasibility, and sustainability of the adapted WHO E-PrEP Implementation Tool. The first aim will be addressed
through concept mapping and bottleneck analysis with policymakers, health officials, and targeted intervention
staff to visualize stakeholder priorities for PrEP implementation. The second aim will be addressed using
conjoint analysis experiments conducted with patients and providers assessing bundled intervention attributes
to elucidate the relative importance of each attribute on the likelihood of successful implementation. The third
aim will involve a pilot cluster randomized controlled trial to evaluate implementation processes and outcomes
along the HIV prevention continuum for testing, linkage, PrEP uptake, retention, and adherence.
Dr. Fehrenbacher’s training objectives correspond with each of these specific aims, as follows: 1) to
gain expertise in implementation science methods; 2) to gain expertise in the design and adaptation of eHealth
interventions; and 3) to gain expertise in monitoring and evaluation of longitudinal interventions. The findings
from this implementation science study will aid in the scale-up of sustainable biobehavioral interventions to
reduce HIV disparities among stigmatized groups across India.
项目概要/摘要
Anne E. Fehrenbacher,博士,公共卫生硕士,精神病学系社会流行病学家,
加州大学洛杉矶分校生物行为科学系和公共研究中心 Fogary GloCal 研究员
印度健康研究所。 Fehrenbacher 博士的长期职业目标是成为一名独立的
具有针对污名化人群实施艾滋病毒干预科学的专业知识的调查员。这
拟议的 K01 研究和培训计划将为 Fehrenbacher 博士提供方法论和实践
实现这一目标的技能。本研究将评估一项计划的可接受性、可行性和可持续性
调整了世卫组织 E-PrEP 实施工具,以提高 PrEP 的吸收、保留和依从性。
Fehrenbacher 博士的研究计划将解决由 EPIS 框架指导的三个具体目标
实施科学:1)在政策、结构和组织层面对障碍和促进因素进行建模
采用世卫组织 E-PrEP 实施工具,支持在印度开展有针对性的 PrEP 干预措施; 2)
评估患者和提供者对捆绑干预组件的偏好,以告知适应情况,
世卫组织 E-PrEP 实施工具的本地化和定制; 3)评估可接受性,
改编后的 WHO E-PrEP 实施工具的可行性和可持续性。第一个目标将得到解决
通过与政策制定者、卫生官员的概念图绘制和瓶颈分析以及有针对性的干预
工作人员可视化利益相关者实施 PrEP 的优先事项。第二个目标将通过使用来解决
与患者和提供者进行联合分析实验,评估捆绑干预属性
阐明每个属性对成功实施可能性的相对重要性。第三个
目标将涉及试点集群随机对照试验,以评估实施过程和结果
沿着 HIV 预防连续体进行检测、关联、PrEP 的吸收、保留和依从性。
Fehrenbacher 博士的培训目标与每个具体目标相对应,如下:1)
获得实施科学方法的专业知识; 2) 获得电子医疗设计和适应方面的专业知识
干预措施; 3) 获得监测和评估纵向干预措施的专业知识。研究结果
从这项实施科学研究将有助于扩大可持续生物行为干预措施
减少印度各地受污名群体之间的艾滋病毒差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Elizabeth Fehrenbacher其他文献
Anne Elizabeth Fehrenbacher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 18.22万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 18.22万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 18.22万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 18.22万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 18.22万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 18.22万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 18.22万 - 项目类别:














{{item.name}}会员




